Organigram Global Inc. (OGI) to Acquire Aurora for C$561M

Organigram (OGI) will acquire Aurora for C$561M, or C$7.80 per share, a 93% premium over Aurora's August 2026 price. The deal, pending approvals, is expected to close in January 2027. It follows Aurora's review of Curaleaf's hostile bid.

Original reporting
Published Nov 3, 2026, 2:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Organigram Global Inc. (OGI) to Acquire Aurora for C$561M — source image
Decision brief

The 30-second read

High
01

Why it matters

The deal is expected to reshape market dynamics in the Canadian cannabis industry, with immediate price impacts for both companies.

02

Market read

First‑report M&A of over $400 M in the cannabis sector, likely to move both stocks sharply.

03

What to watch

Regulatory approvals and potential integration challenges could delay value realization.

Relevance 8/10Novelty 8/10Timing: today

Background

Organigram Global Inc. disclosed a definitive agreement to acquire Aurora Cannabis, offering a substantial premium and targeting a January 2027 close.

Market effects

Consolidation in the Canadian cannabis sector may spur further M&A activity.

Canadian cannabis stocks could see broader price adjustments as the deal sets a new valuation benchmark.

The transaction highlights continued investor interest in the global cannabis market.

Counterpoint

The high premium could strain Organigram's balance sheet and dilute existing shareholders.

Key entities

  • Organigram Global Inc.

    Canadian cannabis company expanding through acquisition.

  • Aurora Cannabis Inc.

    Canadian cannabis producer being bought at a premium.

Related articles

$ACBHighAI 9/10

Organigram Strikes A Deal to Acquire Aurora Cannabis

Organigram will acquire Aurora Cannabis for C$561 million (US$402 million), a 93% premium to Aurora's August 10 share price. Aurora shareholders will own 35% of the combined company. British American Tobacco will fund part of the deal. The acquisition aims to strengthen Organigram's position in the European cannabis market. Aurora's shares rose 21%, while Organigram's fell 2.6%.

$OGIHighAI 9/10

Organigram to acquire Aurora Cannabis for C$561 million

Organigram (OGI) will acquire Aurora Cannabis (ACB) for C$561 million, offering C$7.80 per share in cash, stock, or a mix. The deal values Aurora at a 93% premium over its August 10 closing price and a 21% premium over Curaleaf's rejected bid. Aurora shareholders will hold 35% economic ownership and 42% voting rights in the combined entity.

$ACBMedAI 9/10

Aurora shareholders get an offer from Organigram, 93% above the price before Curaleaf's bid.

Organigram to acquire Aurora for C$7.80 per share, a 93% premium over Aurora's unaffected price. The deal, supported by both boards, values Aurora at approximately C$1.33B. Aurora shareholders can choose cash, shares, or a mix. The combined company aims to enhance scale, supply chain, and global footprint. Organigram's significant shareholder, BAT, will participate in financing.